Control Bionics is excited to announce that NeuroNode® has been listed as a third-party assistive technology device on Apple’s website. Apple’s inclusion of the NeuroNode in its Apple-approved assistive technologies underscores NeuroNode’s versatility and...
Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching...
Control Bionics Ltd (ASX: CBL) is pleased to announce the appointment of Jeremy Steele as Chief Executive Officer and a member of the board, effective from 19 January 2023. Mr. Steele brings over 25 years of global corporate experience across a wide range of...
There have been several recent updates to the NeuroNode Controller App. It has a slightly new layout, but overall retains the same look and feel as the previous version. This update introduces several new features to the NeuroNode Controller App, the key features...
Control Bionics CEO Rob Wong spoke with Holly Shields, business reporter at Kalkine Media, about the new advances in products, regional growth, and exciting partnerships the company has entered into. Wong also highlights user story Glenn Sargood, a Control Bionics...
Control Bionics was featured in an article by Kalkine Media discussing our NeuroNode Trilogy and its distinct tech feature. To deliver on our vision of giving a voice to those with physical and speech challenges, we have combined our NeuroNode Trilogy system with eye...
